<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33837098</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>20</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>09</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Effects of an optimised approach to home-based respiratory care in individuals with amyotrophic lateral sclerosis: a study protocol for a randomised controlled trial.</ArticleTitle><Pagination><StartPage>e042780</StartPage><MedlinePgn>e042780</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e042780</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2020-042780</ELocationID><Abstract><AbstractText Label="INTRODUCTION">This study aims to investigate the effects of an optimal home-based respiratory care protocol in individuals with amyotrophic lateral sclerosis (ALS).</AbstractText><AbstractText Label="METHODS AND ANALYSIS">This is a randomised, blinded controlled trial involving patients diagnosed with ALS, both sexes, age between 18 and 80 years. Patients will be randomly allocated into the conventional respiratory care (CRC) group and the optimised respiratory care home-based (ORC) group. Primary outcomes will be peak cough flow, the number of exacerbations and ALS Functional Rating Scale Revised. Secondary outcomes will include chest wall volumes, maximal respiratory pressures, sniff nasal inspiratory pressure, nasal expiratory pressure and forced vital capacity (FVC), forced expiratory volume in the 1st second (FEV<sub>1</sub>) and FEV<sub>1</sub>/FVC. The CRC group will receive educational information about respiratory care at the clinic. The ORC group will receive conventional care and home-based care. The clinical status of all individuals will be monitored weekly through telephone calls. A 6-month intervention is planned, the outcomes will be assessed every 3&#x2009;months and 3 and 6 months follow-up after final evaluation. The primary and secondary results will be described as average or median for continuous variables and absolute and relative frequencies for qualitative variables. Treatment effects or differences between the outcomes (baseline, 3&#x2009;months and 6&#x2009;months) of the study groups will be analysed using an analysis of variance. The level of significance will be set as p&#x2264;0.05.</AbstractText><AbstractText Label="ETHICS AND DISSEMINATION">The research ethics committee approved the study. It is expected to evaluate respiratory function in patients with ALS in the short, medium and long terms with home-based care protocol applied. The disease's rapid progression is a limitation for performing a long-term clinical study.</AbstractText><AbstractText Label="TRIAL REGISTRATION NUMBER">RBR-3z23ts; Pre-results.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pondofe</LastName><ForeName>Karen</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-2105-1096</Identifier><AffiliationInfo><Affiliation>Departamento de Fisioterapia, PneumoCardioVascular Lab/HUOL e Laborat&#xf3;rio de Inova&#xe7;&#xe3;o Tecnol&#xf3;gica em Reabilita&#xe7;&#xe3;o, Hospital Universit&#xe1;rio Onofre Lopes, Empresa Brasileira de Servi&#xe7;os Hospitalares (EBSERH), Universidade Federal do Rio Grande do Norte, Natal, Brazil karenpondofe@yahoo.com.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fregonezi</LastName><ForeName>Guilherme A F</ForeName><Initials>GAF</Initials><AffiliationInfo><Affiliation>Departamento de Fisioterapia, PneumoCardioVascular Lab/HUOL e Laborat&#xf3;rio de Inova&#xe7;&#xe3;o Tecnol&#xf3;gica em Reabilita&#xe7;&#xe3;o, Hospital Universit&#xe1;rio Onofre Lopes, Empresa Brasileira de Servi&#xe7;os Hospitalares (EBSERH), Universidade Federal do Rio Grande do Norte, Natal, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brito</LastName><ForeName>Ozana</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Departamento de Fisioterapia, PneumoCardioVascular Lab/HUOL e Laborat&#xf3;rio de Inova&#xe7;&#xe3;o Tecnol&#xf3;gica em Reabilita&#xe7;&#xe3;o, Hospital Universit&#xe1;rio Onofre Lopes, Empresa Brasileira de Servi&#xe7;os Hospitalares (EBSERH), Universidade Federal do Rio Grande do Norte, Natal, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dourado J&#xfa;nior</LastName><ForeName>Mario Emilio</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Medicina Integrada, Hospital Universit&#xe1;rio Onofre Lopes, Empresa Brasileira de Servi&#xe7;os Hospitalares (EBSERH), Universidade Federal do Rio Grande do Norte, Natal, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres-Castro</LastName><ForeName>Rodrigo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Departamento de Kinesiolog&#xed;a, Universidad de Chile, Santiago de Chile, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Resqueti</LastName><ForeName>Vanessa R</ForeName><Initials>VR</Initials><AffiliationInfo><Affiliation>Departamento de Fisioterapia, PneumoCardioVascular Lab/HUOL e Laborat&#xf3;rio de Inova&#xe7;&#xe3;o Tecnol&#xf3;gica em Reabilita&#xe7;&#xe3;o, Hospital Universit&#xe1;rio Onofre Lopes, Empresa Brasileira de Servi&#xe7;os Hospitalares (EBSERH), Universidade Federal do Rio Grande do Norte, Natal, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ReBec</DataBankName><AccessionNumberList><AccessionNumber>RBR-3z23ts</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D000078325">Clinical Trial Protocol</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012119" MajorTopicYN="N">Respiration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012129" MajorTopicYN="N">Respiratory Function Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012138" MajorTopicYN="N">Respiratory Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014797" MajorTopicYN="N">Vital Capacity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">clinical trials</Keyword><Keyword MajorTopicYN="N">motor neurone disease</Keyword><Keyword MajorTopicYN="N">neuromuscular disease</Keyword><Keyword MajorTopicYN="N">rehabilitation medicine</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>10</Day><Hour>5</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33837098</ArticleId><ArticleId IdType="pmc">PMC8043034</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2020-042780</ArticleId><ArticleId IdType="pii">bmjopen-2020-042780</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis:, Andersen PM, Abrahams S, et al. . EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force. Eur J Neurol 2012;19:360&#x2013;75. 10.1111/j.1468-1331.2011.03501.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2011.03501.x</ArticleId><ArticleId IdType="pubmed">21914052</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrin C, Unterborn JN, Ambrosio Carolyn D', et al. . Pulmonary complications of chronic neuromuscular diseases and their management. Muscle Nerve 2004;29:5&#x2013;27. 10.1002/mus.10487</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.10487</ArticleId><ArticleId IdType="pubmed">14694494</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui AJ, Byl NN. A systematic review of the effect of moderate intensity exercise on function and disease progression in amyotrophic lateral sclerosis. J Neurol Phys Ther 2009;33:68&#x2013;87. 10.1097/NPT.0b013e31819912d0</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NPT.0b013e31819912d0</ArticleId><ArticleId IdType="pubmed">19556916</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Logroscino G, Traynor BJ, et al. . Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology 2013;41:118&#x2013;30. 10.1159/000351153</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000351153</ArticleId><ArticleId IdType="pmc">PMC4049265</ArticleId><ArticleId IdType="pubmed">23860588</ArticleId></ArticleIdList></Reference><Reference><Citation>Prado LdeGR, Bicalho ICS, Vidigal-Lopes M, et al. . Amyotrophic lateral sclerosis in Brazil: case series and review of the Brazilian literature. Amyotroph Lateral Scler Frontotemporal Degener 2016;17:282&#x2013;8. 10.3109/21678421.2016.1143011</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2016.1143011</ArticleId><ArticleId IdType="pubmed">26854959</ArticleId></ArticleIdList></Reference><Reference><Citation>Dietrich-Neto F, Callegaro D, Dias-Tosta E, et al. . Amyotrophic lateral sclerosis in Brazil: 1998 national survey. Arq Neuropsiquiatr 2000;58:607&#x2013;15. 10.1590/S0004-282X2000000400002</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0004-282X2000000400002</ArticleId><ArticleId IdType="pubmed">10973098</ArticleId></ArticleIdList></Reference><Reference><Citation>Moraes L, Goldbaum M, Silva HCA, et al. . Incidence rate of amyotrophic lateral sclerosis (ALS) in Sao Paulo City, Brazil, 1991&#x2013;1997. Arq Neuro-Psiquiatr 1998;56:343.</Citation></Reference><Reference><Citation>MND Guideline Development Group . Guidelines for the physiotherapy management of motor neuron disease (MND. Dublin: Irish Hospice Foundation, 2014.</Citation></Reference><Reference><Citation>Swinnen B, Robberecht W. The phenotypic variability of amyotrophic lateral sclerosis. Nat Rev Neurol 2014;10:661&#x2013;70. 10.1038/nrneurol.2014.184</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.184</ArticleId><ArticleId IdType="pubmed">25311585</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnus T, Beck M, Giess R, et al. . Disease progression in amyotrophic lateral sclerosis: predictors of survival. Muscle Nerve 2002;25:709&#x2013;14. 10.1002/mus.10090</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.10090</ArticleId><ArticleId IdType="pubmed">11994965</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews JA, Meng L, Kulke SF, et al. . Association between decline in slow vital capacity and respiratory insufficiency, use of assisted ventilation, tracheostomy, or death in patients with amyotrophic lateral sclerosis. JAMA Neurol 2018;75:58&#x2013;64. 10.1001/jamaneurol.2017.3339</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.3339</ArticleId><ArticleId IdType="pmc">PMC5833488</ArticleId><ArticleId IdType="pubmed">29181534</ArticleId></ArticleIdList></Reference><Reference><Citation>Polkey MI, Lyall RA, Yang K, et al. . Respiratory muscle strength as a predictive biomarker for survival in amyotrophic lateral sclerosis. Am J Respir Crit Care Med 2017;195:86&#x2013;95. 10.1164/rccm.201604-0848OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201604-0848OC</ArticleId><ArticleId IdType="pmc">PMC5214920</ArticleId><ArticleId IdType="pubmed">27494149</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, et al. . The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (phase III). J Neurol Sci 1999;169:13&#x2013;21. 10.1016/S0022-510X(99)00210-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, et al. . Esclerose lateral amiotr&#xf3;fica. Nat Rev Dis Primers 2017;3:17071.</Citation><ArticleIdList><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Laghi F, Tobin MJ. Disorders of the respiratory muscles. Am J Respir Crit Care Med 2003;168:10&#x2013;48. 10.1164/rccm.2206020</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.2206020</ArticleId><ArticleId IdType="pubmed">12826594</ArticleId></ArticleIdList></Reference><Reference><Citation>Kravitz RM. Airway clearance in Duchenne muscular dystrophy. Pediatrics 2009;123 Suppl 4:S231&#x2013;5. 10.1542/peds.2008-2952G</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2008-2952G</ArticleId><ArticleId IdType="pubmed">19420150</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith JA, Aliverti A, Quaranta M, et al. . Chest wall dynamics during voluntary and induced cough in healthy volunteers. J Physiol 2012;590:563&#x2013;74. 10.1113/jphysiol.2011.213157</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2011.213157</ArticleId><ArticleId IdType="pmc">PMC3379701</ArticleId><ArticleId IdType="pubmed">22144580</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Mauro A, Aliverti A. Physiology of respiratory disturbances in muscular dystrophies. Breathe 2016;12:318&#x2013;27. 10.1183/20734735.012716</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/20734735.012716</ArticleId><ArticleId IdType="pmc">PMC5297947</ArticleId><ArticleId IdType="pubmed">28210319</ArticleId></ArticleIdList></Reference><Reference><Citation>Macpherson CE, Bassile CC. Pulmonary physical therapy techniques to enhance survival in amyotrophic lateral sclerosis: a systematic review. J Neurol Phys Ther 2016;40:165&#x2013;75. 10.1097/NPT.0000000000000136</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NPT.0000000000000136</ArticleId><ArticleId IdType="pubmed">27164308</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan A-W, Tetzlaff JM, Altman DG, et al. . Spirit 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med 2013;158:200&#x2013;7. 10.7326/0003-4819-158-3-201302050-00583</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-158-3-201302050-00583</ArticleId><ArticleId IdType="pmc">PMC5114123</ArticleId><ArticleId IdType="pubmed">23295957</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, et al. . El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2000;1:293&#x2013;9. 10.1080/146608200300079536</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Branco LMT, Zanao T, De Rezende TJ, et al. . Transcultural validation of the ALS-CBS cognitive section for the Brazilian population. Amyotroph Lateral Scler Frontotemporal Degener 2017;18:60&#x2013;7. 10.1080/21678421.2016.1211147</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1211147</ArticleId><ArticleId IdType="pubmed">27534257</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . Global health estimates 2016: deaths by cause, age, sex, by country and by region, 2000-2016. Geneva, 2018.</Citation></Reference><Reference><Citation>Malachias MVB, Souza W, Plavnik FL. Vii Brazilian guidelines on dyslipidemias and prevention of atherosclerosis. Arq Bras Cardiol 2016;107:1&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5319472</ArticleId><ArticleId IdType="pubmed">27819380</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyung WJ, Sook JL, Sang BK. Effects of mechanical inspiration and expiration exercise on velopharyngeal incompetence in subacute stroke patients. J Rehabil Med 2018.</Citation><ArticleIdList><ArticleId IdType="pubmed">30426133</ArticleId></ArticleIdList></Reference><Reference><Citation>Faul F, Erdfelder E, Buchner A, et al. . Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods 2009;41:1149&#x2013;60. 10.3758/BRM.41.4.1149</Citation><ArticleIdList><ArticleId IdType="doi">10.3758/BRM.41.4.1149</ArticleId><ArticleId IdType="pubmed">19897823</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura F, Fujimura C, Ishida S, et al. . Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology 2006;66:265&#x2013;7. 10.1212/01.wnl.0000194316.91908.8a</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000194316.91908.8a</ArticleId><ArticleId IdType="pubmed">16434671</ArticleId></ArticleIdList></Reference><Reference><Citation>Rooney J, Burke T, Vajda A, et al. . What does the ALSFRS-R really measure? A longitudinal and survival analysis of functional dimension subscores in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2017;88:381&#x2013;5. 10.1136/jnnp-2016-314661</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-314661</ArticleId><ArticleId IdType="pubmed">27888187</ArticleId></ArticleIdList></Reference><Reference><Citation>Francis K, Bach JR, DeLisa JA. Evaluation and rehabilitation of patients with adult motor neuron disease. Arch Phys Med Rehabil 1999;80:951&#x2013;63. 10.1016/S0003-9993(99)90089-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0003-9993(99)90089-8</ArticleId><ArticleId IdType="pubmed">10453774</ArticleId></ArticleIdList></Reference><Reference><Citation>Aliverti A, Dellac&#xe0; R, Pelosi P, et al. . Compartmental analysis of breathing in the supine and prone positions by optoelectronic plethysmography. Ann Biomed Eng 2001;29:60&#x2013;70. 10.1114/1.1332084</Citation><ArticleIdList><ArticleId IdType="doi">10.1114/1.1332084</ArticleId><ArticleId IdType="pubmed">11219508</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller MR, Hankinson J, Brusasco V. ATS/ERS. Task Force. Standardisation of spirometry. Eur Respir J 2005;26:319&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">16055882</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira C, Sato T, Rodrigues SC. New reference values for forced spirometry in adult white Brazilians. J Bras de Pneumol 2007;33:397&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pubmed">17982531</ArticleId></ArticleIdList></Reference><Reference><Citation>Lofaso F, Nicot F, Lejaille M, et al. . Sniff nasal inspiratory pressure: what is the optimal number of sniffs? Eur Respir J 2006;27:980&#x2013;2. 10.1183/09031936.06.00121305</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.06.00121305</ArticleId><ArticleId IdType="pubmed">16455823</ArticleId></ArticleIdList></Reference><Reference><Citation>Ara&#xfa;jo PRS, Resqueti VR, Nascimento Junior J, et al. . Reference values for sniff nasal inspiratory pressure in healthy subjects in Brazil: a multicenter study. J Bras Pneumol 2012;38:700&#x2013;7. 10.1590/s1806-37132012000600004</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/s1806-37132012000600004</ArticleId><ArticleId IdType="pubmed">23288114</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichikawa T, Yokoba M, Kimura M, et al. . Genioglossus muscle activity during sniff and reverse sniff in healthy men. Exp Physiol 2018;103:1656&#x2013;65. 10.1113/EP086995</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP086995</ArticleId><ArticleId IdType="pubmed">30242925</ArticleId></ArticleIdList></Reference><Reference><Citation>Neder JA, Andreoni S, Lerario MC, et al. . Reference values for lung function tests. II. maximal respiratory pressures and voluntary ventilation. Braz J Med Biol Res 1999;32:719&#x2013;27. 10.1590/S0100-879X1999000600007</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0100-879X1999000600007</ArticleId><ArticleId IdType="pubmed">10412550</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>